LNA 📈 LNA Sante SA - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0004170017
LNA: Healthcare, Retirement, Rehabilitation, Surgery, Mental Health, Hospital
LNA Santé SA engages in the management and operation of health establishments. The company operates retirement homes, medical and rehabilitation care, home hospital, surgery, mental health clinic, and health center. LNA Santé SA was founded in 1990 and is based in Vertou, France. Web URL: https://www.lna-sante.com
Additional Sources for LNA Stock
LNA Stock Overview
Market Cap in USD | 246m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception |
LNA Stock Ratings
Growth 5y | -52.9% |
Fundamental | 58.8% |
Dividend | 53.4% |
Rel. Strength Industry | 983 |
Analysts | - |
Fair Price Momentum | 20.97 EUR |
Fair Price DCF | 320.01 EUR |
LNA Dividends
Dividend Yield 12m | 2.58% |
Yield on Cost 5y | 1.31% |
Annual Growth 5y | 5.64% |
Payout Consistency | 93.6% |
LNA Growth Ratios
Growth Correlation 3m | 3.8% |
Growth Correlation 12m | 60.5% |
Growth Correlation 5y | -83.7% |
CAGR 5y | -12.41% |
CAGR/Mean DD 5y | -0.36 |
Sharpe Ratio 12m | 0.49 |
Alpha | 1.88 |
Beta | 0.48 |
Volatility | 32.50% |
Current Volume | 6.9k |
Average Volume 20d | 3.6k |
What is the price of LNA stocks?
As of December 21, 2024, the stock is trading at EUR 23.30 with a total of 6,894 shares traded.
Over the past week, the price has changed by -2.51%, over one month by -1.27%, over three months by -1.48% and over the past year by +25.25%.
As of December 21, 2024, the stock is trading at EUR 23.30 with a total of 6,894 shares traded.
Over the past week, the price has changed by -2.51%, over one month by -1.27%, over three months by -1.48% and over the past year by +25.25%.
Is LNA Sante SA a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, LNA Sante SA (PA:LNA) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.79 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LNA as of December 2024 is 20.97. This means that LNA is currently overvalued and has a potential downside of -10%.
Partly, yes. Based on ValueRay Fundamental Analyses, LNA Sante SA (PA:LNA) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.79 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LNA as of December 2024 is 20.97. This means that LNA is currently overvalued and has a potential downside of -10%.
Is LNA a buy, sell or hold?
LNA Sante SA has no consensus analysts rating.
LNA Sante SA has no consensus analysts rating.
What are the forecast for LNA stock price target?
According to ValueRays Forecast Model, LNA LNA Sante SA will be worth about 22.7 in December 2025. The stock is currently trading at 23.30. This means that the stock has a potential downside of -2.79%.
According to ValueRays Forecast Model, LNA LNA Sante SA will be worth about 22.7 in December 2025. The stock is currently trading at 23.30. This means that the stock has a potential downside of -2.79%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 29.8 | 27.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 22.7 | -2.8% |